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Abstract. We have produced human cyclin A  in 
Escherichia coli and investigated how it generates H1 
kistone kinase activity when added to cyclin-free ex- 
tracts prepared from parthenogenetically activated 
Xenopus eggs. Cyclin A was found to form a major 
complex with cdc2, and to bind cdk2/Egl only poorly. 
No lag phase was detected between the time when cy- 
clin A was added and the time when H1 histone ki- 
nase activity was produced in frog extracts, even in 
the presence of 2 mM vanadate, which blocks cdc25 
activity. Essentially identical results were obtained 
using extracts prepared from starfish oocytes. We con- 
clude that formation of an active cyclin A-cdc2 kinase 
during early development escapes an inhibitory mech- 
anism that delays formation of an active cyclin B-cdc2 
kinase. This inhibitory mechanism involves phosphor- 
ylation of cdc2 on tyrosine 15. Okadaic acid (OA) ac- 
tivated cyclin B-cdc2 kinase and strongly reduced 
tyrosine phosphorylation of cyclin B-associated cdc2, 
even in the presence of vanadate. 6-dimethylamino- 
purine, a reported inhibitor of serine-threonine ki- 
nases, suppressed OA-dependent activation of cyclin 
B-cdc2 complexes. This indicates that the kinase(s) 
which phosphorylate(s) cdc2 on inhibitory sites can be 
inactivated by a phosphorylation event, itself antag- 
onized by an OA-sensitive, most likely type 2A phos- 
phatase. 
We also found that cyclin B- or cyclin A-cdc2 ki- 
nases can induce or accelerate conversion of the cyclin 
B-cdc2 complex from an inactive into an active ki- 
nase. Cyclin B-associated cdc2 does not undergo de- 
tectable phosphorylation on tyrosine in egg extracts 
containing active cyclin A-cdc2 kinase, even in the 
presence of vanadate. We propose that the active cy- 
clin A-cdc2 kinase generated without a lag phase from 
neo-synthesized cyclin A and cdc2 may cause a rapid 
switch in the equilibrium of cyclin B-cdc2 complexes 
to the tyrosine-dephosphorylated and active form of 
cdc2 during early development, owing to strong inhi- 
bition of the cdc2-specific tyrosine kinase(s). This may 
explain why early cell cycles are so rapid in many 
species. 
NTRY into mitosis depends on the activation of  matura- 
tion-promoting  factor  (MPF), t  a  stoichiometric 
complex between cdc2, a  protein kinase catalytic 
subunit and cyclin B, a regulatory subunit (for reviews, see 
Nurse, 1990; and Dorte, 1990). The pathway of MPF activa- 
tion is not fully understood, although there is evidence that 
newly synthesized  cyclin B  binds  to inactive  monomeric 
cdc2, promoting a series of posttranslational  modifications 
of cdc2 that lead first to accumulation of the complex in an 
inactive form (Solomon et al.,  1990). These modifications 
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include phosphorylation  of Tyr 15 and Thr 14 (Gould and 
Nurse, 1989; Norbury et al., 1991; Krek and Nigg,  1991). 
Conversion  into an active kinase is due to the activity of 
cdc25,  which dephosphorylates Tyr 15  (Strausfeld et al., 
1991; Gautier et al., 1991; Dunphy and Kumagal, 1991; Mil- 
lar et al.,  1991; Lee et al.,  1992) and probably Thr 14. 
In most animals, including Xenopus and Drosophila, early 
development is characterized by a series of rapid and syn- 
chronous cell cycles which takes place after fertilization. 
These cell cycles are believed to be a sequence of S phase 
and M phase without intervening  G phases.  After this an 
abrupt transition,  the midblastula  transition  (Signoret and 
Lefresne, 1971) takes place,  leading to more complex cell 
cycles similar to those observed in somatic cells. After this 
transition,  divisions become asynchronous and slower, ow- 
ing to the addition of G phases. Oscillations of MPF activity, 
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work of microtubules, as well as cleavages, are independent 
of DNA  replication  in  early  embryos;  they  continue  in 
enucleated eggs (Briggs  et al.,  1951; Picard et al.,  1988; 
Dabauvalle et al., 1988) and in the presence of the replica- 
tion inhibitor aphidicolin (Kimelman et al., 1987; Picard et 
al.,  1987; Raft and Glover,  1988).  After the midblastula 
transition however,  cell cycle arrests if DNA replication is 
incomplete. 
Mitotic cyclin cDNAs have been cloned and sequenced 
from a variety of organisms, and on the basis of sequence ho- 
mologies in the most conserved central 200 amino acids (the 
cyclin box), have been subdivided into two classes, the A 
type and the B type (for review see Nugent et al., 1991). Both 
types of cyclins also contain a conserved but slightly differ- 
ent stretch of aminoacids (the destruction box) in its NH:- 
terminal  region,  whose  integrity  is  required  for  cell  cy- 
cle-regulated proteolysis by a  ubiquitin-dependent system 
(Glotzer et al.,  1990;  Lorca et al.,  1991). Although cyclin 
A has also been reported to be required for DNA replication 
in somatic cells (Girard et al.,  1991; Zindy et al.,  1992; 
Pagano et al., 1992) and to maintain dependence of mitosis 
on  completion  of DNA  replication  (Walker  and  Mailer, 
1991) observations that cyclin A mutants in Drosophila ar- 
rest at G2 of the sixteenth cell cycle (Lehner and O'Farrell, 
1990),  and that truncated cyclin A, like truncated cyclin B 
(Murray et al., 1989; Ghiara et al., 1991) arrests Spisula em- 
bryos at M phase (Luca et al., 1991; Lorca et al., 1992) argue 
that cyclin A is required for and plays an essential role in mi- 
tosis, perhaps more specifically during early embryogenesis. 
Cyclin B-cdc2 kinase activity rises more smoothly than 
that of  the cyclin A-cdc2 complex during the first mitotic cell 
cycle in Xenopus, (Minshull et al., 1990) and probably does 
so in other early embryos (Westendorf et al.,  1989).  This 
suggested that the mechanism of formation of active cyclin 
A-cdc2 kinase might not be the same as that of cyclin B-cdc2 
kinase. In the present work we found that recombinant cyclin 
A forms extremely rapidly an active complex with cdc2 in 
egg extracts, and this even in conditions which prevent cdc25 
to dephosphorylate inhibitory residues in cdc2. This indi- 
cates that cdc2 undergoes limited phosphorylation on inhib- 
itory residues in cyclin A,  as compared to cyclin B com- 
plexes.  We also found that cyclin A-cdc2 kinase can trigger 
activation of the cyclin B-cdc2 complex in such extracts, at 
least partially by inhibiting a tyrosine kinase which phos- 
phorylates cdc2 on inhibitory residues. This suggests that at 
least during early embryogenesis, cyclin A potentiates acti- 
vation of MPF by limiting the phosphorylation of cyclin 
B-associated cdc2 on inhibitory residues. 
Materials and Methods 
Egg Extracts 
Interphase Xenopus  extracts were prepared as follows: unfertilized eggs 
were dejellied in 2% cysteine, and transferred in MMR/2 (50 mM NaCI, 
1 mM KCI, 0.5 mM MgC12,  1 mM CaC12, 0.05 mM Na-EGTA, 2.5 mM 
Na-Hepes, pH 7.7).  Cycloheximide (100  #g/ml) was added and the eggs 
were electrically activated 15 min later. Extracts were prepared 25 min after 
activation, as described by Murray and Kirschner (1989),  except that cyclo- 
heximide (20 #g/mi) was present throughout the procedure. Metaphase ex- 
tracts were prepared the same way from cycloheximide-treated but unacti- 
vated eggs. 
Starfish extracts were prepared from oocytes arrested at G2 as described 
elsewhere (Labb6 et al., 1991), and centrifuged at 105,000 g for 1 h before 
using supernatants for experiments. 
CDC2 Kinase and Recombinant Proteins 
Starfish cyclin B-cdc2 kinase was prepared as previously described (Labb6 
et al.,  1989a,  1991). 
Human cyclins A (both the full-length and a A46-truncated protein), the 
starfish A58 cyclin B fused at its COOH terminus with the human serum 
albumin (HSA) binding site of streptococcal protein G, and human CDC25 
were produced as described (Lorca et al.,  1992;  Strausfeld et al.,  1991). 
Plasmids encoding Xenopus cyclin A and cdc2 were generous gifts of Dr. 
Karsenti (EMBL, Heidelberg, Germany) and Jean Gautier (University of 
California, San Francisco, CA). 
lmmunodetection  and Affinity Purification 
Inununoprecipitations were performed after diluting samples in RIPA buffer 
(150 mM NaC1, 2 mM EDTA, 50 mM NaE  10 mM Na-glycerophosphate, 
0.5% Na-deoxycholate, 1% NP-40,  10 mM Na-phosphate, pH 7.6) and im- 
mune complexes isolated on protein A-Sepharose. In some experiments pro- 
tein A-Sepharose beads cross-linked to  affinity-purified antibodies were 
used (Schneider et al.,  1982).  For Western blots we used a chemilumines- 
cence detection system (Amersham International, Amersham, England). 
Unless otherwise specified complexes containing the starfish fusion protein 
were isolated on HSA-Sepharose beads after dilution in RIPA buffer.  For 
fixation of cdc2-containing complexes on pl 3sucl-Sepharose,  samples were 
diluted 10-fold in a buffer containing 80 mM fl-glycerophosphate, 20 mM 
EGTA, 10 mM DTT, 5 mM EDTA and 50 mM NaF at pH 7.3 before adding 
the beads, prepared as already described (Labb~ et al.,  1991). 
Proteolytic Cleavages 
Tryptic digestion was performed in 0.1% (wt/vol) ammonium bicarbonate 
with 0.1 nag of TPCK-trypsin (Serva, Heidelberg, Germany) at 37~  After 
16 h, TPCK-trypsin was added a second time. After 8 h the gel piece was 
removed and the supernatant lyophilized. 
The resulting peptide mixture was further digested in 0.1% ammonium 
bicarbonate  by  endoproteinase-Glu-C  (Boehringer  Mannheim  GmbH, 
Mannheim, Germany), from Staphylococcus aureus V8 (0.02 rag) overnight 
at 37~  The digestion was stopped by lyophilization. 
Phosphoamino Acids Analysis and Peptide Mapping 
Phosphoamino acids analysis was carried out according to Cooper et al. 
(1983).  Phosphopeptide mapping was carried out either by monodimen- 
sional thin layer electrophoresis (TLE) or by TLE followed by ascending 
chromatography on cellulose thin layer plates (TLC).  Monodimensional 
electrophoresis was run at pH 1.9 in formic acid-acetic acid-water (50-156- 
1794,  vol/vol/vol/vol) according to Boyle et al. (1991). For bidimensional 
peptide mapping, electrophoresis was at pH 3.5  in pyridine-acetic acid- 
water (10-100-1890, vol/vol/vol) with migration toward the cathode followed 
by  ascending chromatography  right  angle  in  isobutyric acid-n butanol- 
pyridine-acetic acid-water (1250-38-96-58-558,  vol/vol/vol/vol/vol) as in 
Boyle et al.  (1991). 
Phosphopeptide Synthesis 
Solid phase synthesis of the Val Tyr Thr His Glu peptide was performed 
on a 9050 Milligen Synthetizer (Watford, U.K.), with the use of pep Syn 
KA resin and FMOC as temporary c~ amino acid protection. Upon comple- 
tion of the peptide chain assembly the only free hydroxyl group of Thr resi- 
due was phosphorylated according to Otvos et al. (1989),  cleaved from the 
resin with a TFA-water-phenol mixture and further purified by ionic ex- 
change chromatography  on  a  Mono  Q  HR  5/5  column  eluted  with  a 
0-0.5 M ammonium bicarbonate linear gradient and lyophilization of the 
phosphopeptide-containing fractions. 
Ill Histone Kinase Assays 
Aliquots  of extracts  or  afffinity-purified  cyclin-cdc2 complexes were 
diluted in  10 vol of a buffer containing 20 mM Hepes, pH 7.4,  10 mM 
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ATP (200 cpm/pmol) and incubated at 25~  Reactions were stopped after 
5 or 10 min either with Laemmli's buffer or by spotting on pieces of P81 
phosphocellulose paper and extensive dilution in water. 
Results 
Formation of  Inactive Cyclin B-cdc2 complex in 
Xenopus Eggs Extracts 
Pioneer experiments by Murray and Kirschner (1989) dem- 
onstrated that addition of truncated sea urchin cyclin B (A90 
and A13) to an interphase Xenopus egg extract activates MPF 
and drives the extract into a mitotic state. It was later shown 
that the heterologous cyclin binds monomeric Xenopus  cdc2, 
promoting a series of posttranslational modifications of the 
chimeric kinase that lead to the transient accumulation of an 
inactive complex with cdc2 phosphorylated on tyrosine and 
threonine inhibitory residues. Activation of  this complex was 
blocked by vanadate, which inhibits phosphatase activity of 
cdc25 (Solomon et al.,  1990). 
We also obtained such results in some interphase frog ex- 
tracts (see Materials and Methods) using a  tagged protein 
containing residues 59-388 of starfish cyclin B fused at its 
COOH-terminus  with  the  HSA binding  domain  of strep- 
tococcal protein G (Fig.  1, type 2  extracts). In other inter- 
phase  extracts  however  (type  1  extracts,  Fig.  1),  cyclin 
B-cdc2 complexes were formed but they remained damped 
in an inactive state, even in the absence of vanadate. The 
same result has been obtained occasionally by others using 
either the sea urchin A90 cyclin (see Fig. 3 in Glotzer et al., 
1991)  or recombinant Xenopus B1  cyclin (Clarke,  P.,  and 
Karsenti,  E., personal communication). In our hands,  fre- 
quency of extracts behaving in the second way was highest 
(near 75%) when eggs were preincubated with cyclohexi- 
mide before parthenogenetic activation, preventing protein 
synthesis to occur during preparation of extracts. Cdc2 ki- 
nase remained inactive for hours in such extracts, even when 
cdc2 was saturated by adding 240 nM cyclin B. As expected, 
cyclin was not phosphorylated, and cdc2 phosphorylated on 
threonine and tyrosine residues in the inactive complex (data 
not shown). 
Besides Tyr 15 and Thr 14, binding to cyclin induces the 
phosphorylation of cdc2 on another residue, Thr 161 (Krek 
and Nips,  1991; Solomon et al.,  1992; Lorca et al.,  1992) 
or  its homologue Thr  167  in  fission yeast (Gould et al., 
1991). Phosphorylation of Thr 161 on cdc2 is believed to be 
required for either stabilization (Ducommun et al., 1991) or 
alternatively to  confer H1  kinase  activity to  cyclin-cdc2 
complexes (Solomon et al.,  1992).  To investigate whether 
Thr 161 was phosphorylated in inactive cyclin B-cdc2 com- 
plexes, cyclin B was added together with 3,-32P-ATP  (6 mCi/ 
ml) to interphase extracts. For this and the following experi- 
ments we used extracts which did not support "spontaneous" 
activation  of cyclin B-cdc2  complexes,  even  after  a  lag 
phase. 30 min later cyclin B-containing complexes were im- 
munoprecipitated and either treated for 10 min in the ab- 
sence of ATP with recombinant human cdc25, or left un- 
treated. In both cases, complexes were eluted, components 
separated by SDS-PAGE and analyzed by autoradiography. 
As shown in Fig. 2 a, cdc2 shifted almost quantitatively to 
a higher mobility form after cdc25 treatment, indicating that 
dephosphorylation of  inhibitory residues had occurred. None- 
Figure L Starfish cyclin B can generate either inactive or active 
complexes with Xenopus ode2,  depending on extracts.  Recom- 
binant starfish cyclin B (160 nM) was added to two interphase frog 
extracts prepared in the same way (see Material and Methods) but 
from two different females. Aliquots were taken as a function of 
time and treated with the same amount of pl3S~l-Sepharose  beads. 
The retained material was either eluted with Laemmli's buffer, ana- 
lyzed by SDS-PAGE, and Western blotted or transferred with the 
beads in a reaction mix designed to measure HI kinase activity (see 
Materials  and  Methods).  Blots  were  probed  first  with  anti- 
phosphotyrosine  antibodies  (top) then  with  antibodies  (called 
NMPF) directed against a 12 amino acid peptide corresponding to 
the conserved NH2-terminal sequence of cdc2 (middle). The lower 
panel shows an autoradiogram of H1 kinase activities in the differ- 
ent aliquots. Aliquots were taken before (0) or 5 (1), 15 (2), 60 (3) 
and  90 min  (4) after cyclin B addition.  Cyclin B-cdc2 kinase 
reached its maximal activity within 30 min and remained stable 
thereafter because the cyclin B fusion protein lacks the destruction 
box and does  not undergo utiquitin-dependent pmteolysis.  Note 
that the dephosphoD'lated cdc2 monomer does not bind efficiently 
p13  sur  as already reported (Devault et al.,  1991). 
theless  25--45%  of the  initial  radioactivity were  still  as- 
sociated with cdc2 after cdc25 treatment (Fig. 2 b), and as- 
signed to phosphothreonine by phosphoamino acids analysis 
(not shown). To map the phosphorylated threonine residue, 
cdc2 was cut out from the gel, treated with both trypsin and 
the V8 protease, and the resulting material submitted to bi- 
dimensional analysis and autoradiography. A single spot was 
detected after treatment with cdc 25, which migrated as the 
synthetic phosphopeptide  Val-Tyr-TDhr-His-Glu (Fig.  2  c). 
& 
This sequence is that of  the peptide spanning Thr 161 in cdc2 
that would be expected to be generated by proteolysis under 
such conditions. We conclude that even in its inactive form, 
the complex which accumulates in interphase extracts upon 
cyclin B addition contains a Thr 161-phosphorylated cdc2 
subunit. 
Potentiation of  Cyclin B-cdc2 Complex Activation by 
Cyclin A- or Cyclin B-cdc2 Kinases 
The inactive cyclin B-cdc2 complex formed in interphase 
Devault et al. Cyclin A Inhibits Tyrosine Phosphorylation of CDC2  11 t 1 Figure 2. Cdc2 is phosphorylated on Thr 161 in inactive cyclin B-cdc2 complexes. Cyclin B (160 nm) was added together with 3,-32P-ATP 
(6 mCi/ml) to an interphase extract. 30 min later cyclin B-containing complexes were immunoprecipitated with anti-starfish cyclin B anti- 
bodies and the immunoprecipitate split into two equal parts. One was treated for 10 min in the absence of ATP with recombinant human 
cdc25. Both the cdc25-treated and non-treated immunoprecipitates were eluted with Laemmli's  buffer and proteins separated by SDS-PAGE. 
(a) Autoradiograrn of the untreated (1) and the cdc25-treated aliquots (2). Arrowheads point to ode2. (b) Densitometric scanning of ode2 
in lanes 1 and 2 from the autoradiograrn. (c) The cdc2 bands were cut out from lanes 1 and 2, digested with both trypsin and the V8 
protease, and the resulting material submitted to bidimensional analyis and autoradiography. The arrowhead on each autoradiogram points 
to the position of the Val-Tyr-Thr-His-Glu  phosphopeptide (detected with a ninhydrin spray) run simultaneously with the labeled samples. 
P 
frog extracts appeared to be similar, if not identical, to pre- 
MPF,  the inactive cyclin B-ode2 complex which accumu- 
lates in G2-arrested oocytes of at least some species (Gautier 
and Mailer, 1991; Kumagai and Dunphy, 1991; Strausfeld et 
al.,  1991).  Indeed both complexes can be activated even in 
the absence of ATP by cdc25, which dephosphorylates the 
inhibitory residues in cdc2. One of the most characteristic 
properties of MPF is its ability to be amplified in serial trans- 
fers in which the recipient of a transfer becomes the donor 
of the next one (Masui and Markert, 1971; Kishimoto et al., 
1982). During this process, the microinjected cyclin B-edc2 
kinase converts pro-MPF into active cyclin B-cdc2 kinase 
(Labb6 et al.,  1987 and  1989). The amplification loop be- 
comes activated when cyclin B-ode2 kinase activity exceeds 
a threshold value, which depends on species and can be low- 
ered by inhibiting type 2A phosphatase activity (Dor6e et 
al.,  1991;  Picard et al.,  1991). 
This led us to investigate the effect of adding active cyclin 
B-cdc2 kinase to interphase extracts containing the inactive 
complex.  Highly  purified  starfish  cyclin  B-edc2  kinase 
(Labb6 et al., 1989) was added to the final HI histone kirmse 
activity of 8 pmol/min//zl to interphase extracts containing 
an inactive cyclin B-ode2 complex generated by adding 70 
nM  starfish cyclin B.  15  min later cdc2-containing com- 
plexes were recovered on pl3suol-Sepharose beads and either 
assayed for H1 historic kinase activity or Western blotted and 
analyzed with anti-phosphotyrosine antibodies. A threefold 
higher kinase activity was recovered when starfish ode2 ki- 
nase was added to extracts containing the inactive complex, 
and this was associated with disappearance of phosphotyro- 
sine from ode2 (not shown). We conclude that cyclin B-ode2 
kinase can  activate in  frog extracts an amplification loop 
which converts the in vitro assembled complex from an inac- 
tive into an active protein kinase,  as it does in oocytes. 
Cyclin A microinjection also readily activates MPF in (32- 
arrested oocytes (Swenson et al.,  1986) and it does so even 
more efficiently than cyclin B (Roy et al.,  1991). In the next 
experiments, we investigated whether cyclin A-ode2 kinase 
could trigger conversion of inactive cyclin B-ode2 kinase in 
frog extracts. We could not use starfish cyclin A-edc2 ki- 
nase, because starfish cyclin A has not yet been character- 
ized. Therefore we generated a chimeric complex between 
recombinant human cyclin A, produced in Escherichia coli 
(see Materials and Methods) and frog edc2 in interphase egg 
extracts.  Besides  forming a  protein kinase  complex with 
cdc2, as cyclin B does, cyclin A has been shown to associate 
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complex with cdc2 in interphase frog extracts. (a) Aliquots were 
taken 30 min after adding increasing amounts of human cyclin A 
to interphase extracts and HI histone kinase activities measured in 
anti-cyclin A immunoprecipitates. M indicates the level of HI his- 
tone kinase activity found in the equivalent volume of crude extract 
prepared from metaphase H-arrested eggs. (b) 2 #1 of reticulocyte 
lysate containing equal amounts of either 3~S-labeled  human cdc2 
or Xenopus cdk2/Egl  (~104 cpm) were added to 20 #1 of inter- 
phase extract. 5 min later, cyclin A (120  riM) was added. After in- 
cubation for 30 min, cyclin A-containing complexes were isolated 
on anti-cyclin A beads and analyzed by SDS-PAGE  and fluorogra- 
phy. In control experiments performed in the absence of cyclin A, 
neither cdc2 nor cdkl/Egl were found to bind to the anti-cyclin A 
beads (not shown). Arrowheads point to the expected positions of 
p34  cdc2 (left) and p32  cdk2 (right). (c) The material immunoprecipi- 
tated by anti-cyclin A antibodies after cyclin A addition to Xenopus 
extracts was  analyzed by Western blotting with two antibodies: 
(PSTAIR)  Recognizes both cdc2 and cdk2/Egl; and (NMPF) Recog- 
nizes cdc2 and does not cross-react with Egl. Arrowheads point to 
p34  ~dc2. 
in somatic ceils with cdk2, a related protein containing the 
PSTAIR epitope found in the cdc2 family (Paris et al., 1991; 
Pines and Hunter, 1990; Elledge and Spottswood, 1991). In 
the active HI kinase complex which formed in egg extracts, 
however, most cyclin A was associated to cdc2, not cdk2, for 
the following reasons:  (a) cdk2 is about 20-fold less abun- 
dant than cdc2 in frog extract (Gabrielli et al., 1992). There- 
fore it could not contribute a significant part of the large H1 
kinase activity produced at saturating cyclin A  concentra- 
tion, which reached approximately threefold the level found 
in  the  equivalent volume of crude extract prepared from 
metaphase II-arrested eggs (Fig. 3 a); (b) when cyclin A was 
added  to  extracts  containing  identical  amounts  of  35S- 
labeled human cdc2 or Xenopus  cdk2 proteins, both trans- 
lated in the  reticulocyte system, much more radioactivity 
was co-immunoprecipitated with cyclin A in the first than in 
the second case, although cdk2 contains a similar number of 
methionine residues as cdc2 (Fig.  3 b); and (c) anti-cyclin 
A immunoprecipitates contained a single major protein (34 
kD)  cross-reacting  with  both  an  antibody  against  the 
PSTAIR peptide, which recognizes both cdc2 and cdk2, and 
an  antibody  directed  against  the  12  amino  acids  NH~- 
terminal sequence of cdc2, which does not cross-react with 
cdk2 (Fig.  3  c). 
An  inactive cyclin B-cdc2 complex was  isolated by af- 
finity on HSA-Sepharose beads  from a  frog extract com- 
plemented  with  the  starfish  cyclin  B  fusion  protein  and 
treated with another aliquot of the same extract containing 
the active human cyclin A-cdc2 kinase. 30 min later, the cy- 
clin B-cdc2 complex was checked both for HI histone kinase 
activity and tyrosine phosphorylation of  the cdc2 subunit. As 
shown in Fig. 4 a and b, both tyrosine dephosphorylation and 
kinase activation had  occurred.  No  cyclin B-cdc2 kinase 
activation occurred when the complex was treated with an 
extract  lacking  cyclin  A.  The  possibility  that  the  HSA- 
Sepharose matrix used to recover the cyclin B-cdc2 com- 
plexes had been contaminated by the cyclin A-cdc2 kinase 
was ruled out by showing that no cyclin A had relocated from 
the extract to the HSA-Sepharose beads (Fig. 4 d) and that 
no loss of H1 kinase activity had occurred in the extract after 
incubation with the beads (Fig. 4 a, compare lanes 3 and 4). 
It could also be argued that activation of the cyclin B-cdc2 
complexes involved the exchange of cdc2 subunits between 
both types of cdc2 complexes. This was most unlikely since 
extracts in which all the available cdc2 subunits had been en- 
gaged in inactive complexes with cyclin B did neither support 
formation of cyclin A-cdc2 complexes (Fig. 4 e) nor H1 his- 
tone kinase activation (data not shown) upon cyclin A addi- 
tion. This confirms that both cyclin A and cyclin B kinase 
complexes share in common cdc2 as the catalytic subunit 
and shows in addition that cyclin A-cdc2 kinase, not merely 
cyclin A, is required for activation of the amplification loop. 
This experiment also excludes the possibility that despite its 
low-abundancy cyclin A-cdk2 might be the active complex 
catalyzing pre-MPF activation because cyclin B  does not 
bind and therefore would not be expected to deplete cdk2 
from extracts. 
We conclude that both active cyclin B- and cyclin A-cdc2 
kinases can trigger conversion of the inactive cyclin B-cdc2 
complex into an active complex. As described above (Fig. 
1), some interphase frog extracts support "spontaneous" acti- 
vation of cyclin B-cdc2 kinase after a  lag phase.  This lag 
phase was shortened when active cyclin B- or cyclin A-cdc2 
kinases were added to such extracts (data not shown). 
Cyclin A-cdc2 Complex Does Not Require cdc25 
for Its Activation 
One of the most intriguing differences between cyclin A and 
cyclin B is the timing of activation of their associated protein 
kinases during cell cycle. In the early Xenopus embryo, cy- 
clin A-cdc2 kinase reaches a maximum when cyclin B-cdc2 
kinase activity is just beginning  to rise  (Minshull  et al., 
1990). This led us to investigate the kinetics of  cyclin A-cdc2 
kinase activation in egg extracts. 
As shown on Fig. 5 a, no lag phase could be demonstrated 
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clin  B-cdc2 complex activa- 
tion in interphase frog extracts. 
An  inactive  cyclin  B-cdc2 
complex, made in a  frog ex- 
tract by adding starfish  cyclin 
B  fusion  protein  (160  rim), 
was affinity-purified  on HSA- 
Sepharose  (see Fig. 2). It was 
transferred  in aliquots  of frog 
extract  precincubated  for  30 
min in the presence (2) or ab- 
sence  (1)  of  cyclin  A  (120 
nM). 30 min later it was recov- 
ered and checked for cdc2 de- 
phosphorylation and kinase ac- 
tivation.  (a) HI histone kinase 
activities were measured in pu- 
rified  cyclin B-cdc2 complex 
(1 and 2) as well as in frog ex- 
tracts  (3 and 4) before adding 
(3) or after depleting  (4) the 
cyclin B-cdc2 complexes.  (b) 
The  purified  cyclin  B-ode2 
complex was Western blotted 
and analyzed for p34  ~c2 dephosphorylation with affinity-purified  antibodies  against  either PSTAIR (left)  or phosphotyrosine (right).  (c 
and d) Affinity-purified  B-cdc2 complexes,  isolated  either before (1) or after activation  (2),  as well as the material  immunoprecipitated 
from cyclin A-containing frog extracts  with purified  antibodies  against  human cyclin A, either before adding (3) or after depleting  (4) 
the cyclin B-cdc2 complexes,  were run on polyacrylamide gels.  Western  blots were analyzed for the presence of either starfish  cyclin B 
or human cyclin A with the corresponding antibodies  (c, anti-cyclin B; d, anti-cyclin  A). (e) Human cyclin A (120 nM) was added in a 
frog extract containing either no starfish  cyclin B, or 240 nM starfish  cyclin B. 30 min later cyclin A was immunoprecipitated as above 
and the immunoprecipitated materials  were run on polyacrylamide gels.  Western blots were analyzed for the presence of either cyclin A 
or p34  "de2 with the corresponding antibodies. 
between the time when human cyclin A  was added and the 
time when H1 kinase activity was produced in frog extracts. 
Nonetheless,  a  faint  amount  of  tyrosine-phosphorylated 
cdc2 was detected in immunoattinity-purified cyclin A-cdc2 
complex.  It was  removed  when  immunoprecipitates  were 
treated with bacterially produced cdc25 (Fig. 5 b). Absence 
of a detectable lag phase could be due to a  very short half 
life  of the  inactive  and tyrosine-phosphorylated complex. 
However, vanadate did not prevent cyclin A-cdc2 kinase acti- 
vation (Fig.  5 a), rather suggesting that direct formation of 
the active complex bypassed the step of tyrosine phosphory- 
lation.  Similar  results  were  obtained  using  recombinant 
Xenopus  cyclin A  (data  not shown). 
To test the generality of the rapid and vanadate-insensitive 
Figure 5.  Mechanism of formation of active 
cyclin  A-cdc2  kinase  in  frog  extracts.  (a) 
Time course of cyclin A-cdc2 kinase activa- 
tion in interphase frog extracts  after addition 
of recombinant human cyclin  A  (120 nM). 
Samples  were taken  at the  indicated  times 
from extracts  receiving or not (control) cy- 
clin A at zero time, diluted  30-fold  in water 
and immediately  frozen in liquid nitrogen. HI 
histone kinase activities  were measured sub- 
sequently  in the thawed samples.  An experi- 
ment was run in parallel  with 2 mM vanadate 
included in the extract,  to block cdc25 activ- 
ity. This did not block cyclin A kinase activa- 
tion.  (b)  The  material  immunoprecipitated 
with antibodies  against human cyclin A from 
samples  taken at time 10 rain in experiment 
depicted in panel a was analyzed by immu- 
noblotting  with  anti-phosphotyrosine  anti- 
bodies.  (1) Sample containing cyclin A. (2) 
Sample without cyclin A. (3) Sample contain- 
ing cyclin A but the immunoprecipitate was 
treated  with cdc25 before  running the gel. 
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ment, we also used extracts prepared from starfish oocytes. 
Immature starfish oocytes arrested at G2 contain an inactive 
cyclin B-cdc2 complex (Strausfeld et al.,  1991).  This com- 
plex could be converted to its active form in the extracts by 
adding bacterially produced cdc25, and as expected this was 
blocked by 2 mM vanadate. When cyclin A was added in a 
parallel experiment to such extracts, HI kinase activity rap- 
idly formed, even without cdc25 addition. Moreover this cy- 
clin A-cdc2 kinase activity was generated without delay even 
in the presence of 2  mM vanadate (data not shown). 
Failure of vanadate to suppress or delay formation of ac- 
tive cyclin A-cdc2 complexes in egg extracts prepared from 
various species indicates that cdc25 activity is not required 
for cyclin A to form an active complex with cdc2, at least 
in the early embryo. 
We demonstrated in the previous section that addition to 
Xenopus  egg  extracts  of either  cyclin  A-cdc2  or  cyclin 
B-cdc2  active kinases  can  turn  on an  amplification loop 
which converts the cyclin B-cdc2 complex into an active pro- 
tein kinase complex. The finding that cyclin A-cdc2 kinase 
forms without lag phase in egg extracts, and thus escapes the 
inhibitory mechanism that delays cyclin B-cdc2 kinase acti- 
vation, strongly suggests that cyclin A-cdc2 kinase may actu- 
ally potentiate MPF activation in the early embryo. 
Cyclin A-cdc2 Kinase Inhibits 
~rosine Phosphorylation of cdc2 in 
Cyclin B-cdc2 Complexes 
Since  the  cyclin  B-cdc2  complex  generated  by  adding 
starfish cyclin B to interphase frog extracts is already phos- 
phorylated on Thr 161 (Fig. 2), its conversion to an active 
form due to the presence of active cyclin A-cdc2 kinase in 
egg extracts could be due to a reduction in the activity of ld- 
nase(s) which phosphorylate(s) cdc2 on inhibitory residues, 
to an increase in the activity of the activating phosphatase 
(cdc25), or to a combination of both events. 
To detect the putative inhibition of a kinase phosphorylat- 
ing Tyr 15,  we examined the time course of cdc2 tyrosine 
phosphorylation following addition of recombinant cyclin B 
to frog extracts containing or not the active cyclin A-cdc2 
kinase.  The inclusion of sodium vanadate, an inhibitor of 
cdc25,  ensured that changes in the accumulation of phos- 
photyrosine were due to the tyrosine kinase alone. Since the 
cdc2 monomer is dephosphorylated and phosphorylation of 
cdc2 in cyclin-cdc2 complexes changes its electrophoretic 
mobility on SDS gels, the rate of tyrosine phosphorylation 
could be compared to the rate of complex formation.  As 
shown in Fig. 6 (top), accumulation of phosphotyrosine in 
cyclin B-associated cdc2 roughly paralleled formation of the 
complex in the absence of cyclin A. In contrast phosphotyro- 
sine was not detectable at any time in cyclin B-associated 
cdc2 when egg extracts contained active cyclin A-cdc2 ki- 
nase.  We  conclude  that  cyclin  A-cdc2  kinase  activity 
strongly reduces activity of the kinase which phosphorylates 
cdc2 on Tyr 15 and maintains the cyclin B-cdc2 complex in 
an inactive state. As expected, H1 kinase activity of cyclin 
B-cdc2 complexes was much higher in vanadate containing 
extracts after activation with cyclin A-cdc2 kinase (Fig. 6, 
bottom). 
Finally, we investigated whether, once modified by cyclin 
A-ode2 kinase,  the egg extract remained able at least for 
Figure 6.  Cyclin A-cdc2 kinase inhibits the tyrosine kinase that 
phosphorylates cdc2 in cyclin B-cdc2 complexes. (Top) Recom- 
binant cyclin B was added (160 riM) to a frog extract containing 
( + cA ) or not (-  cA ) active cyclin A-cdc2 kinase (12 pmol/min/#l), 
generated by adding human cyclin A (60 nM) in frog extracts. So- 
dium vanadate (2 mM) was added before cyclin B addition to inhibit 
cdc25. HSA-Sepharose beads were added to aliquots taken at the 
indicated times (min) and diluted 10-fold in a buffer containing 80 
mM  /3-glycerophosphate, 20 mM  EGTA,  10 mM  DTT, 5  mM 
EDTA, and 50 mM NaF at pH 7.3. Identical amounts of affinity- 
purified cyclin B-containing  complexes were analyzed by SDS- 
PAGE, Western blotted, and the piece of nitrocellulose containing 
cdc2 probed first with antibodies directed against phosphotyrosine 
(aP-Tyr) or with NMPF antibodies directed against cdc2 (t~cdc2). 
Note that only the higher mobility form of cdc2 is detected in ex- 
tracts containing cyclin A-cdc2 kinase (arrowhead, left). To load 
identical amounts of  cdc2 in each lane, Xenopus cdc2 was translated 
in vitro and the resulting 35S-labeled protein used as a tracer to 
quantify the amount of cdc2 recovered on the affinity matrices. 
(Bottom) Same experiment as in upper panel, but affinity-purified 
cyclin B-ode2 complexes were assayed for H1 kinase activity as de- 
scribed in Materials and Methods. 








control  cyc A treated 
E  0  30  E  0  30 
Figure 7. Cyclin A-cdc2 kinase can be removed prior to cyclin 
B-cdc2 complex addition and still promotes its activation in frog 
extracts.  Cyclin A-cdc2  kinase,  covalently bound to Sepharose 
beads, was added or not (control) to a frog extract, and removed 
30 min later. 2 min later (zero time) aliquots of an inactive cyclin 
B-cdc2 complex, generated in a parallel experiment in a non-cyclin 
A-treated  interphase  extract  and  purified  by affinity on  HSA- 
Sepharose, was added either in the cyclin A-treated or in the non 
cyclin A-treated extract (control). H1 kinase activities of the cyclin 
B-cdc2 complexes were assayed either before (0) or 30 min after 
transfer. (E) Basal H1 kinase activities of the extract (no cyclin 
B-cdc2 complex added) as measured either before addition (con- 
trol) or after removal of cyclin A-cdc2 kinase. 
some time to convert the inactive cyclin B-cdc2 complex 
into an active protein kinase complex, even after removing 
cyclin A-cdc2 kinase. For this experiment, human cyclin A 
was covalently linked to Sepharose beads and added to a frog 
extract. The immobilized cyclin A bound cdc2 in the extract, 
and generated an active H1 kinase.  30 min later the beads 
were removed. No significant H1 kinase activity was left in 
the extract. 2 min after cyclin A removal an inactive cyclin 
B-cdc2 complex, produced in another aliquot of the same 
frog extract was  added to the cyclin A-treated aliquot.  It 
readily underwent activation within the next 30 min. No acti- 
vation was observed when the cyclin B-cdc2 complex was 
transferred to non-cyclin A-treated extracts (Fig.  7). 
An Okadaic Acid-Sensitive Phosphatase Activates the 
l~rosine Kinase that Phosphorylates cdc2 
Solomon et al. (1990)  showed that duration of the lag phase 
before activation of  cyclin B-cdc2 kinase in frog extracts was 
shortened by okadaic acid (OA) and lengthened by adding 
purified type 2A phosphatase.  We confirmed that OA or 
microcystin (both 1 #M) readily induces activation of the in 
vitro produced cyclin B-cdc2 complex in Xenopus  extracts, 
whilst inhibitors 1 and 2 had no such effects (Fig. 8). Phos- 
phorylation of  Thr 161 is absolutely required for edc2 kinase 
activation (Gould and Nurse, 1991; Ducornmun et al., 1991; 
Solomon et al.,  1992; Lorca et al.,  1992). We showed that 
Thr 161 is already phosphorylated before activation in cyclin 
B-cdc2 complexes (Fig. 2) and although this was not directly 
determined, we believe that this phosphorylation is stoichio- 
metric because complexes were activated to the same extent 
by adding recombinant cdc25 in the presence or absence of 
ATE  Although  type  2A  phosphatase  was  reported  to 
dephosphorylate a mitosis-specific threonine residue, pre- 
sumably Thr  161, on cdc2  (Lee et al.,  1991),  this  could 
therefore not be its unique target in inhibiting kinase acti- 
vation. 
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Figure 8. OA induces cyclin B-cdc2 complex activation in inter- 
phase frog extracts. OA (1 #M) was added to frog extracts contain- 
ing increasing amounts of the cyclin B fusion protein, and HI his- 
tone kinase was  monitored  30 rain later.  Controls:  HI  histone 
kinase activities in interphase frog extract containing both 240 nM 
cyclin B and a mixture of inhibitors 1 and 2 (both 0.25 #M), but 
no OA. (M) Metaphase extract without addition of cyclin or phos- 
phatase inhibitor. 
plex by OA involved inhibition of a kinase phosphorylating 
Tyr 15, we examined the time course of tyrosine phosphory- 
lation on cdc2 after the addition of recombinant cyclin B to 
frog extracts, in the presence or absence of 1 #M OA. The 
inclusion of sodium vanadate ensured that changes in the ac- 
cumulation of phosphotyrosine were due to the tyrosine ki- 
nase alone. When OA was present in the extract to block ac- 
tivity of type 2A phosphatase, tyrosine phosphorylation of 
cdc2 still occurred to some extent, but it was reduced with 
respect to the untreated extract (Fig. 9 a). In the absence of 
OA,  two bands of tyrosine-phosphorylated cdc2 were ob- 
served. The lower mobility band, which reflects incremental 
phosphorylation of cdc2 on Thr 14, was not observed in OA- 
treated extracts. OA had no effect when it was added only af- 
ter cdc2 had shifted to its lower mobility form. We conclude 
that  inhibition  of  an  OA-sensitive  phosphatase  strongly 
reduces activity of the kinase(s) which phosphorylate(s) Tyr 
15 and Thr 14 on cyclin B-associated cdc2. 
The above results  suggested that  type 2A  phosphatase 
counteracts a serine-threonine kinase inactivating the cdc2- 
specific tyrosine kinase in frog extracts. A reported protein 
kinase  inhibitor,  6-dimethyl-aminopurine (6-DMAP)  has 
been shown to reversibly inhibit cdc2 kinase activation with- 
out inhibiting tyrosine phosphorylation of cdc2 (Neant and 
Guerrier, 1988; Jessus et al.,  1991). In the next experiment 
we took advantage of the apparent selectivity of the protein 
kinase inhibitor. Interphase extracts, containing 2 mM vana- 
date and 1 #M OA, were treated with 0.5 mM DMAP, or not, 
before adding the recombinant starfish cyclin B. 30 min later, 
aliquots were taken and examined for tyrosine phosphoryla- 
ton of cdc2. As shown in Fig. 9, b-d, and in agreement with 
the above hypothesis, the serine/threonine kinase inhibitor 
suppressed the effect  of OA and restored the inhibitory phos- 
phorylation of cdc2 on tyrosine. In this experiment OA com- 
pletely suppressed tyrosine phosphorylation of cdc2 in the 
absence of DMAP. 
Discussion 
In the present work, we found that cdc25 activity is not re- 
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lates cdc2 is activated by an okadaic-sensitive 
phosphatase and inhibited by a DMAP-sensi- 
tive serine/threonine kinase.  (a)  1 #M OA 
was added (+OA) or not (-OA) either  si- 
multaneously (OA/)  or 30 min after (OA2) 
adding at zero time the starfish cyclin B fu- 
sion protein (100 nM) to an interphase frog 
extract containing 2 mM vanadate (to block 
cdc25). Aliquots were taken at the indicated 
times (minutes), and the material retained on 
HSA-Sepharose  beads was analyzed by SDS- 
PAGE, Western-blotted and the pieces of ni- 
trocellulose  containing  cdc2  probed  either 
with anti-phosphotyrosine (r  or with 
anti-NMPF antibodies (otcdc2). All samples 
contained identical amounts of cdc2 (quan- 
tiffed as described in legend to Fig. 6). In a 
parallel experiment OA was added 10 min be- 
fore cyclin B to an extract containing either 
vanadate alone (1) or both vanadate and 0.5 
mM DMAP (2). Aliquots were taken 30 min 
after cyclin B addition and the attinity-puri- 
fled  cyclin B-containing  complexes either 
Western blotted and probed with anti-NMPF 
(b) and anti-phosphotyrosine antibodies (c) 
or assayed for H1 kinase activity (d). 
quired for cyclin A to form an active kinase complex with 
cdc2 in a variety of extracts prepared from oocytes or early 
embryos. This correlates well with the observation that only 
a  small fraction of cyclin A-associated ode2 is ever phos- 
phorylated on tyrosine in Xenopus extracts. It may explain 
why cyclin A-ode2 kinase activation is so rapid relative to 
that of  cyclin B-edc2 kinase which is delayed, if  not blocked, 
by quantitative phosphorylation of Tyr-15 of cdc2. It may be 
worth emphasizing that, whilst Solomon et al. (1990) clearly 
showed that cdc2 undergoes tyrosine phosphorylation only 
after its binding with cyclin B, they did not formally demon- 
strate that tyrosine phosphorylation occurs before kinase ac- 
tivation after binding of cdc2 with cyclin B. Rather they con- 
sistently observed a  low level of H1  historic kinase in the 
presence of vanadate, as well as at early times after cyclin 
B was added in interphase frog extracts, suggesting that at 
least some newly formed cyclin B-cdc2 complexes under- 
went mitotic phosphorylation (at Thr 161) to the exclusion 
of inactivating phosphorylations (at  Thr  14  and  Tyr 15). 
Thus, both cyclin A- and cyclin B-cdc2 complexes may be 
formed essentially according to the same mechanisms, al- 
though cyclin A-associated cdc2 appears to be a relatively 
poor substrate for the tyrosine kinase which phosphorylates 
and inactivates cdc2. 
Interestingly, we found that cyclin B- or cyclin A-ode2 ki- 
nases  can  induce  or  accelerate  conversion of the  cyclin 
B-cdc2 complex from an inactive into an active kinase. This 
is in keeping with results obtained by Solomon et ai. (1990), 
who showed that tyrosine dephosphorylation of cdc2 pro- 
ceeds faster in mitotic than interphase frog extracts. This re- 
sponse appears to be closely related to the process known 
in  oocytes as  MPF  amplification,  which  allows  a  small 
amount of MPF to be rapidly amplified in serial transfer of 
cytoplasm in which the recipient of a transfer becomes the 
donor to the next one, and this even in the absence of protein 
synthesis (Wasserman and Masui,  1975; Dorde, 1982). We 
propose that the active cyclin A-cdc2 kinase generated with- 
out a lag phase from neo-synthesized cyclin A and cdc2 may 
cause a  rapid switch in the equilibrium of cyclin B-cdc2 
complexes  to  the  tyrosine-desphosphorylated  and  active 
form of cdc2. 
The cdc2-specific tyrosine ldnase could be the target ofcy- 
clin A-cdc2 ldnase in potentiating cyclin B-cdc2 kinase acti- 
vation. In agreement with this view, we showed in the present 
work that cyclin B-associated cdc2 did not undergo detect- 
able phosphorylation on tyrosine in egg extracts containing 
active cyclin A-cdc2 kinase, even when cdc25 activity was 
inhibited by vanadate. This was not due to modification of 
the cyclin B-cdc2 complex because of  its phosphorylation by 
cyclin A-cdc2 kinase, because cyclin A-cdc2 kinase could 
be removed from the extract before adding cyclin B. 
Several  observations  indicate  that  completion of DNA 
replication and initiation of mitosis are coupled during cell 
cycle. For example, if inhibitors of DNA synthesis are added 
to dividing cells, these cells will not enter mitosis until the 
inhibitors are removed and replication is completed. Also, 
when cells in S phase are fused to ceils in the G2 phase of 
the cell cycle, the G2 nucleus is delayed from entering mito- 
sis until the S phase nucleus has completed replication (Rao 
and Johnson,  1970).  Inhibition of MPF activation by un- 
replicated DNA has been shown to be mediated by phos- 
phorylation of its ode2 subunit on inhibitory residues, in- 
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Figure I0. Model for cyclin A 
potentiation of MPF  activa- 
tion via inhibition of the ty- 
rosine/threonine kinases that 
phosphorylate  cdc2.  Cyclin 
B-cdc2 kinase  (MPF)  exists 
in either of two major forms, 
an inactive  one with edc2 phos- 
phorylated on residues 14, 15, 
and  161, and  an  active one, 
with cdc2 phosphorylated on 
threonine  161  only, which 
drives  the  cell  from  G2  to 
M phase. The equilibrium be- 
tween both forms depends on 
the activity of homologues of 
the fission yeast wee 1/mik 1 
and  cdc25 gene  products, 
which  respectively  promote 
phosphorylation and dephos- 
phorylate Thr 14 and Tyr 15. 
The wee 1/mik 1 kinases are 
themselves  negatively  con- 
trolled by a phosphorylation 
event catalyzed by homologues 
of the fission yeast niml/cdr kinase, which is antagonized by an OA-sensitive, most likely type 2A, phosphatase. Cyclin A- and cyclin 
B-cdc2 complexes accumulate progressively after their destruction at metaphase of the preceding cell cycle. Both cyclin A- and cyclin 
B-edc2 kinases activities can in principle displace the wee 1/mik 1 equilibrium from its active to its inactive state (by an unknown mecha- 
nism), but in contrast to cyclin B-cdc2, most cyclin A-cdc2 complex escapes inhibitory phosphorylation on edc2, and once formed it 
gains without lag phase kinase activity. This explains why it plays the major (the earlier) role in inactivating wee 1/mik 1. 
cluding Tyr 15 (Kumagai and Dunphy, 1991; Meijer et al., 
1991).  It seems that cdc25 is part of the linkage between 
DNA replication and mitosis: indeed fission yeast mutants 
in cdc2 that are insensitive to cdc25 divide in the presence 
of hydroxyurea, an inhibitor of DNA replication (Enoch and 
Nurse,  1990). 
Recently, it was  reported that ablation of cyclin A over- 
came an aphidicolin block in Xenopus extracts containing 
sperm chromatin, and thereby induced premature entry into 
mitosis (Walker and Mailer, 1991). Ablation of cyclin A had 
no such effect in the absence of added nuclei. This was taken 
as indicating that association of cyclin A with the nucleus 
was required for unreplicated DNA to block MPF activation. 
Actually, cyclin A rapidly shuttles in the nucleus of somatic 
cells after its translation which starts at late G1 (Pines and 
Hunter,  1991; Girard et al.,  1991),  in contrast to cyclin B 
which does not appear to enter the nucleus before prophase. 
Since cdc25 protein is also primarily localized in the nucleus 
during interphase (Millar et al.,  1991),  this suggested that 
cyclin A could act in the nucleus, most likely in association 
with either cdc2 or cdk2, and prevent cdc25 from activating 
cyclin B-cdc2 kinase. 
Cyclin A may however play a different role in early em- 
bryos where the dependence of M  phase on S phase is not 
observed. The rate of sequestration of cyclin A  by the nu- 
cleus would be expected to be reduced in early embryos, ow- 
ing to their high ratio of cytoplasm to nuclei. In agreement 
with this view, cyclin A was shown to be cytoplasmic during 
interphase in the early Drosophila embryo, and to relocate 
to the nucleus only at late prophase (Lehner and O'Farrell, 
1989; Maldonado-Codina and Glover, 1992). This may also 
hold true for cdc25,  although information is  lacking.  In- 
terestingly, null mutants of cyclin A were found to arrest at 
G2 before the sixteenth mitosis, after maternal cyclin A had 
been exhausted, even though they accumulated cyclin B. This 
suggested that cyclin A could be required for MPF activation 
in early embryos, even though it may not play this role in so- 
matic cells, owing to its rapid sequestration in the nucleus. 
We propose, therefore, that in early embryos cyclin A, be- 
ing mostly cytoplasmic, forms spontaneously an active com- 
plex with cdc2 kinase that, by inactivating the cdc2-specific 
tyrosine kinase, prevents the inactivation of cyclin B-cdc2 
kinase (Fig. 10). This might explain why early cell cycles are 
so rapid in most animals and would be in agreement with ear- 
lier reports that no tyrosine phosphorylation of cdc2 could 
be detected in Xenopus embryos during the second to the 
twelfth cell cycle (Ferrell et al.,  1991) and that the tyrosine 
kinase that phosphorylates cdc2 functions in the cytoplasm 
(Kumagai and Dunphy, 1991). Yet, we do not know how cy- 
clin A-cdc2 kinase acts to inactivate the cdc2-specific tyro- 
sine kinase. Nonetheless, we demonstrated that okadaic acid 
strongly reduced phosphorylation of both Tyr 15 and Thr 14 
on cyclin B-associated cdc2, even in the presence of vana- 
date, which suppresses cdc25 activity. This suggested that 
the  kinase(s)  which  phosphorylate(s)  cdc2  on  inhibitory 
sites could be inactivated by a phosphorylation event, itself 
antagonized by an OA-sensitive phosphatase. In agreement 
with this view, we showed that 6-DMAP, a reported inhibitor 
of serine-threonine kinases, suppresses OA-dependent acti- 
,cation of cyclin B-cdc2 complexes. 
In fission yeast, two protein kinases, wee 1 and mik 1, act 
together to maintain cdc2 in the tyrosine phosphorylated, in- 
active  state  (Russell  and  Nurse,  1987;  Lundgren  et  al., 
1991). The wee 1 kinase is able to phosphorylate both seryl 
and  tyrosyl residues  in  vitro  (Featherstone  and  Russell, 
1991). Although wee 1 has not been shown to phosphorylate 
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cells using a baculovirus vector results in phosphorylation 
of cdc2  on  tyrosine,  and  this  phosphorylation  is  greatly 
stimulated  by  co-expressed  cyclin  (Parker  et  al.,  1991). 
These results stongly suggest that wee 1 and mik 1, and their 
homologues in higher eukaryotes, catalyze phosphorylation 
of Tyr  15 and Thr 14 on cyclin-associated cdc2. 
Interestingly,  a gene encoding a putative serine/threonine 
kinase, him  1/cdr, has been described as a mitotic inducer 
which operates through negative regulation of wee 1 (Russell 
and Nurse,  1987; Feilotter et al., 1991).  To our knowledge, 
it has not been investigated whether mutations in nim 1/cdr 
are epistatic to mutations in ppa2, the gene encoding the ma- 
jor type 2A phosphatase in fission yeast (Kinoshita et al., 
1990).  Our results  suggest that type 2A phosphatase might 
antagonize the products of niml/cdr homologues, if they ex- 
ist in higher eukaryotes. 
Although  cdc25  is  actually  phosphorylated  and  thus 
potentially regulated during cell cycle (Moreno et al., 1990), 
it is unclear whether phosphorylation of cdc25 might be a 
late event in the process of cdc2  kinase activation during 
early development. Indeed the inactive cyclin B-cdc2 com- 
plex stored in starfish  or Xenopus oocytes activates either 
spontaneously in crude extracts  depleted of ATP (Labbe et 
al.,  1988,  1989b) or after purification to near homogeneity 
when  non-phosphorylated  recombinant  cdc25  is  added 
(Strausfeld et al., 1991). Moreover cdc25 extracted from G2- 
arrested oocytes is reported to be biologically as active as 
that  from  metaphase-arrested  eggs  (Jessus  and  Beach, 
1992). Phosphorylation of cdc25 might serve other purposes 
and regulate for example its nuclear localization or its associ- 
ation with other components during cell cycle. Nonetheless 
we did not address in the present work the question as to 
whether cyclin A-cdc2 kinase also activates  cdc25 in egg ex- 
tracts,  besides inactivating  the tyrosine kinase which phos- 
phorylates cdc2 on inhibitory sites.  This remains open for 
future  investigations. 
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